医学
风险评估
家庭医学
重症监护医学
儿科
经济
管理
作者
Doreen M. Rabi,Kerry A. McBrien,Ruth Sapir‐Pichhadze,Meranda Nakhla,Sofia B. Ahmed,Sandra M. Dumanski,Sonia Butalia,Alexander A. C. Leung,Kevin C. Harris,Lyne Cloutier,Kelly B. Zarnke,Marcel Ruzicka,Swapnil Hiremath,Ross D. Feldman,Sheldon W. Tobe,Tavis S. Campbell,Simon Bacon,Kara Nerenberg,George K. Dresser,Anne Fournier
标识
DOI:10.1016/j.cjca.2020.02.086
摘要
Hypertension Canada’s 2020 guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children provide comprehensive, evidence-based guidance for health care professionals and patients. Hypertension Canada develops the guidelines using rigourous methodology, carefully mitigating the risk of bias in our process. All draft recommendations undergo critical review by expert methodologists without conflict to ensure quality. Our guideline panel is diverse, including multiple health professional groups (nurses, pharmacy, academics, and physicians), and worked in concert with experts in primary care and implementation to ensure optimal usability. The 2020 guidelines include new guidance on the management of resistant hypertension and the management of hypertension in women planning pregnancy.
科研通智能强力驱动
Strongly Powered by AbleSci AI